Compound ID | 457
Class: Beta-lactam
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to penicillin binding proteins (PBPs), especially PBP2; PBP2 inhibitor |
| Description: | Bicyclic pyrazolidinone scaffold; derivative of LY173013 |
| Institute where first reported: | Eli Lilly, US |
| Year first mentioned: | 1986 |
| Development status: | Experimental |
| Reason dropped: | Superseded by later compounds such as LY193239 which demonstrated higher potency through affinity for PBP enzymes |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6918048 |
| Citations: |
|